Pressure Mounts On FDA After Public Release Of Surveillance Documents

Multiple investigations and lawsuits have opened in response to the matter, with more potentially to come. Some worry the intensifying issue has serious implications for the quality of the device center’s output.

More from Legal & IP

More from Policy & Regulation